• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于胞外5'-核苷酸酶(CD73)的荧光探针。

Fluorescent Probes for Ecto-5'-nucleotidase (CD73).

作者信息

Schmies Constanze C, Rolshoven Georg, Idris Riham M, Losenkova Karolina, Renn Christian, Schäkel Laura, Al-Hroub Haneen, Wang Yulu, Garofano Francesca, Schmidt-Wolf Ingo G H, Zimmermann Herbert, Yegutkin Gennady G, Müller Christa E

机构信息

PharmaCenter Bonn, Pharmaceutical Institute, Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany.

MediCity Research Laboratory, University of Turku, 20520 Turku, Finland.

出版信息

ACS Med Chem Lett. 2020 Sep 3;11(11):2253-2260. doi: 10.1021/acsmedchemlett.0c00391. eCollection 2020 Nov 12.

DOI:10.1021/acsmedchemlett.0c00391
PMID:33214837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7667873/
Abstract

Ecto-5'-nucleotidase (CD73) catalyzes the hydrolysis of AMP to anti-inflammatory, immunosuppressive adenosine. It is expressed on vascular endothelial, epithelial, and also numerous cancer cells where it strongly contributes to an immunosuppressive microenvironment. In the present study we designed and synthesized fluorescent-labeled CD73 inhibitors with low nanomolar affinity and high selectivity based on benzyl-α,β-methylene-ADP (PSB-12379) as a lead structure. Fluorescein was attached to the benzyl residue via different linkers resulting in PSB-19416 (, 12.6 nM) and PSB-18332 (, 2.98 nM) as fluorescent high-affinity probes for CD73. These compounds are anticipated to become useful tools for biological studies, drug screening, and diagnostic applications.

摘要

胞外5'-核苷酸酶(CD73)催化AMP水解为具有抗炎、免疫抑制作用的腺苷。它在血管内皮细胞、上皮细胞以及众多癌细胞上表达,在这些细胞中它对免疫抑制微环境有重要作用。在本研究中,我们基于苄基-α,β-亚甲基-ADP(PSB-12379)作为先导结构,设计并合成了具有低纳摩尔亲和力和高选择性的荧光标记CD73抑制剂。荧光素通过不同的连接子连接到苄基残基上,得到了PSB-19416(,12.6 nM)和PSB-18332(,2.98 nM)作为CD73的荧光高亲和力探针。预计这些化合物将成为生物学研究、药物筛选和诊断应用的有用工具。

相似文献

1
Fluorescent Probes for Ecto-5'-nucleotidase (CD73).用于胞外5'-核苷酸酶(CD73)的荧光探针。
ACS Med Chem Lett. 2020 Sep 3;11(11):2253-2260. doi: 10.1021/acsmedchemlett.0c00391. eCollection 2020 Nov 12.
2
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors.α,β-亚甲基-ADP(AOPCP)衍生物和类似物:高效且选择性的外核苷酸酶(CD73)抑制剂的开发。
J Med Chem. 2015 Aug 13;58(15):6248-63. doi: 10.1021/acs.jmedchem.5b00802. Epub 2015 Jul 30.
3
Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.甲氨蝶呤上调胞外5'-核苷酸酶/CD73并降低胶质母细胞瘤微环境中T淋巴细胞的频率。
Purinergic Signal. 2016 Jun;12(2):303-12. doi: 10.1007/s11302-016-9505-8. Epub 2016 Feb 24.
4
Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.肠致病性大肠杆菌的外切-5'-核苷酸酶与肠道离子分泌。
Purinergic Signal. 2007 Jun;3(3):233-46. doi: 10.1007/s11302-007-9056-0. Epub 2007 May 17.
5
The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.胞外5'-核苷酸酶在内皮功能障碍和血管病变中的作用。
Pharmacol Rep. 2015 Aug;67(4):675-81. doi: 10.1016/j.pharep.2015.05.002. Epub 2015 May 16.
6
Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells.甲状腺激素可增加血管平滑肌细胞中外切5'-核苷酸酶/CD73的活性和表达。
Mol Cell Biochem. 2006 Sep;289(1-2):65-72. doi: 10.1007/s11010-006-9148-0. Epub 2006 May 23.
7
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.缺氧诱导因子-1对ecto-5'-核苷酸酶(CD73)的调控介导肠道上皮细胞的通透性变化。
J Clin Invest. 2002 Oct;110(7):993-1002. doi: 10.1172/JCI15337.
8
Involvement of CD73 (ecto-5'-nucleotidase) in adenosine generation by human gingival fibroblasts.CD73(胞外5'-核苷酸酶)在人牙龈成纤维细胞生成腺苷中的作用。
J Dent Res. 2003 Nov;82(11):888-92. doi: 10.1177/154405910308201108.
9
IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.干扰素-α诱导内皮细胞产生腺苷:一种由CD73(胞外5'-核苷酸酶)上调介导的机制。
J Immunol. 2004 Feb 1;172(3):1646-53. doi: 10.4049/jimmunol.172.3.1646.
10
The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.胞外5'-核苷酸酶/CD73在胶质瘤细胞系增殖中的作用。
Mol Cell Biochem. 2008 Dec;319(1-2):61-8. doi: 10.1007/s11010-008-9877-3. Epub 2008 Jul 18.

引用本文的文献

1
CD73: agent development potential and its application in diabetes and atherosclerosis.CD73:药物研发潜力及其在糖尿病和动脉粥样硬化中的应用
Front Immunol. 2024 Dec 12;15:1515875. doi: 10.3389/fimmu.2024.1515875. eCollection 2024.
2
CD73: Friend or Foe in Lung Injury.CD73:肺损伤的友敌。
Int J Mol Sci. 2023 Mar 14;24(6):5545. doi: 10.3390/ijms24065545.
3
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.癌症中的 ATP 和腺苷代谢:治疗增益的探索。
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.
4
CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.CD73 控制眼内腺苷水平,保护视网膜免受光诱导的光毒性。
Cell Mol Life Sci. 2022 Feb 25;79(3):152. doi: 10.1007/s00018-022-04187-4.
5
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.3-甲基胞苷-5'-α,β-亚甲基二磷酸酯作为 CD73 抑制剂的构效关系。
J Med Chem. 2022 Feb 10;65(3):2409-2433. doi: 10.1021/acs.jmedchem.1c01852. Epub 2022 Jan 26.
6
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A Adenosine Receptor Antagonist So Far.迄今为止,FSCPX 被认为是一种选择性不可逆 A 腺苷受体拮抗剂,有大量间接证据表明其具有不可逆的外核苷酸酶抑制作用。
Int J Mol Sci. 2021 Sep 11;22(18):9831. doi: 10.3390/ijms22189831.
7
The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).哺乳动物胞外 5′-核苷酸酶(CD73)的优雅复杂性。
Trends Cell Biol. 2021 Oct;31(10):829-842. doi: 10.1016/j.tcb.2021.05.008. Epub 2021 Jun 8.

本文引用的文献

1
Discovery of AB680: A Potent and Selective Inhibitor of CD73.AB680 的发现:一种强效且选择性的 CD73 抑制剂。
J Med Chem. 2020 Oct 22;63(20):11448-11468. doi: 10.1021/acs.jmedchem.0c00525. Epub 2020 Jul 20.
2
The adenosine pathway in immuno-oncology.免疫肿瘤学中的腺苷途径。
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629. doi: 10.1038/s41571-020-0382-2. Epub 2020 Jun 8.
3
Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia.癌细胞中腺苷代谢的区室化及其在急性缺氧期间的调节。
J Cell Sci. 2020 May 29;133(10):jcs241463. doi: 10.1242/jcs.241463.
4
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.发现强效和选择性非核苷酸小分子 CD73 抑制剂。
J Med Chem. 2020 Apr 23;63(8):3935-3955. doi: 10.1021/acs.jmedchem.9b01713. Epub 2020 Apr 8.
5
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.2-取代的 α,β-亚甲基-ADP 衍生物:具有可变结合模式的强效竞争性外核苷酸酶 (CD73) 抑制剂。
J Med Chem. 2020 Mar 26;63(6):2941-2957. doi: 10.1021/acs.jmedchem.9b01611. Epub 2020 Feb 28.
6
Adenosine Metabolism: Emerging Concepts for Cancer Therapy.腺苷代谢:癌症治疗的新兴概念。
Cancer Cell. 2019 Dec 9;36(6):582-596. doi: 10.1016/j.ccell.2019.10.007.
7
Ectonucleotidases: Potential Target in Drug Discovery and Development.外核苷酸酶:药物研发中的潜在靶点
Mini Rev Med Chem. 2019;19(11):866-869. doi: 10.2174/138955751911190517102116.
8
An Exceptionally Potent Inhibitor of Human CD73.一种人 CD73 的超强抑制剂。
Biochemistry. 2019 Aug 6;58(31):3331-3334. doi: 10.1021/acs.biochem.9b00448. Epub 2019 Jul 23.
9
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.嘌呤和嘧啶核苷酸作为胞外5'-核苷酸酶(CD73)抑制剂的构效关系
J Med Chem. 2019 Apr 11;62(7):3677-3695. doi: 10.1021/acs.jmedchem.9b00164. Epub 2019 Mar 21.
10
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.可溶性和膜结合的腺苷酸激酶和核苷酸酶增强了伴有玻璃体积血的糖尿病性视网膜病变眼中 ATP 介导的炎症反应。
J Mol Med (Berl). 2019 Mar;97(3):341-354. doi: 10.1007/s00109-018-01734-0. Epub 2019 Jan 7.